CRISPR Genome Editing and the Future of Down Syndrome Treatment
The ethics of using safe gene therapies to improve the health and cognition of Down syndrome children and adults.
Opening excerpt (first ~120 words) tap to expand
Gene Editing CRISPR Genome Editing and the Future of Down Syndrome Treatment The ethics of using safe gene therapies to improve the health and cognition of Down syndrome children and adults. Ronald Bailey | 4.30.2026 11:30 AM Share on FacebookShare on XShare on RedditShare by emailPrint friendly versionCopy page URL Add Reason to Google Media Contact & Reprint Requests <img src="https://d2eehagpk5cl65.cloudfront.net/img/c800x450-w800-q80/uploads/2026/04/CRISPR-Trisonomy-21-4-16-800x450.png" style="max-width: 100%; height: auto" width="1200" height="675" title="CRISPR genome editing" alt="CRISPR genome editing | Adani Samat / Boghog" /> (Adani Samat / Boghog) Deaf children can now hear thanks to a new treatment that repairs a defective gene.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Reason Magazine.